Literature DB >> 30374404

Pre-eclampsia and maternal-fetal conflict.

P J Varas Enriquez1, L J McKerracher2, M G Elliot3.   

Abstract

Entities:  

Year:  2018        PMID: 30374404      PMCID: PMC6199529          DOI: 10.1093/emph/eoy029

Source DB:  PubMed          Journal:  Evol Med Public Health        ISSN: 2050-6201


× No keyword cloud information.

PRE-ECLAMPSIA

Pre-eclampsia, a pregnancy disorder defined clinically by maternal hypertension and proteinuria, affects 5–10% of pregnancies and is a major cause of perinatal morbidity and mortality [1]. In healthy pregnancy, placental tissue invades maternal uterine arteries causing reduced arterial elasticity and promoting blood supply to the placenta. In early-onset pre-eclampsia (<34 weeks) this invasion is inadequate, resulting in stressed placentas deprived of blood flow and often yielding growth-restricted fetuses. In late-onset pre-eclampsia (≥34 weeks) the condition is characterized more by defects in maternal cardiovascular health than by inadequate placental invasion. In both cases, the results are a pro-inflammatory maternal immune environment, hypertension and blood vessel damage in kidney, liver and brain [2]. The multiple risk factors of pre-eclampsia include poor maternal cardiovascular health (including hypertension and obesity), presence of risk alleles and lack of extended sexual exposure of the mother to the father prior to conception [3].

EVOLUTIONARY PERSPECTIVES

Pre-eclampsia is common only in humans (which have the most invasive form of mammalian placenta). It is reported rarely in other great apes and absent in non-apes. Parent-offspring conflict [4] may underlie the evolutionary maintenance of pre-eclampsia despite its burden of mortality. Increased placental invasion and intimacy of maternal–fetal contact is associated with increased prenatal growth rates (but not absolute size) of brain and body [5, 6]. Since mothers and offspring have different optimal gestation lengths and growth rates, there will be conflict over these phenotypes. One additional benefit to the fetus of invasive placentation is that the metabolic costs of detoxifying harmful byproducts of oxygen metabolism (i.e. oxidative stress) can be offloaded onto the mother by direct secretion of pro-inflammatory substances into her blood [7]. Consequently, alleles promoting or suppressing invasion (of benefit to fetus and mother, respectively) persist in the population and may cause disease in certain genetic combinations or maternal health states. Conflict over placental invasion may be exacerbated by high human prenatal brain growth rates which, along with the unusually long human gestation length, may explain pre-eclampsia’s high frequency in humans but rarity in species with less-demanding fetal brain growth trajectories. Humans have unusually low fecundability, which promotes extended preconception interaction between couples, potentially reducing pre-eclampsia risk through development of maternal tolerance of paternal antigens [3].

FUTURE IMPLICATIONS

Genetic conflict should be expected in all pregnancies and may lead to medical complications. It may be of psychological benefit for expectant parents to anticipate conflict and its potential consequences from the beginning of pregnancy, instead of viewing pregnancy as maternal–fetal harmony. Many mammals exhibit drastically reduced placental invasion in normal pregnancy. Understanding how these species combine low placental invasion with fetal and maternal wellbeing, and how evolutionary transitions between placental types have occurred [7], may contribute to our knowledge of human placental disorders.
  6 in total

1.  Placental invasiveness and brain-body allometry in eutherian mammals.

Authors:  M G Elliot; B J Crespi
Journal:  J Evol Biol       Date:  2008-09-19       Impact factor: 2.411

Review 2.  Genetic conflicts in human pregnancy.

Authors:  D Haig
Journal:  Q Rev Biol       Date:  1993-12       Impact factor: 4.875

3.  An essay of reflection: Why does preeclampsia exist in humans, and why are there such huge geographical differences in epidemiology?

Authors:  Pierre-Yves Robillard; Gustaaf Dekker; Silvia Iacobelli; Gérard Chaouat
Journal:  J Reprod Immunol       Date:  2015-07-11       Impact factor: 4.054

4.  Oxidative stress and the evolutionary origins of preeclampsia.

Authors:  Michael G Elliot
Journal:  J Reprod Immunol       Date:  2016-03-04       Impact factor: 4.054

5.  Placentation and maternal investment in mammals.

Authors:  Isabella Capellini; Chris Venditti; Robert A Barton
Journal:  Am Nat       Date:  2010-11-18       Impact factor: 3.926

6.  IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia?

Authors:  C W Redman; I L Sargent; A C Staff
Journal:  Placenta       Date:  2014-01-11       Impact factor: 3.481

  6 in total
  2 in total

Review 1.  Uteroplacental Circulation in Normal Pregnancy and Preeclampsia: Functional Adaptation and Maladaptation.

Authors:  Xiangqun Hu; Lubo Zhang
Journal:  Int J Mol Sci       Date:  2021-08-11       Impact factor: 5.923

2.  Evolutionary transcriptomics implicates HAND2 in the origins of implantation and regulation of gestation length.

Authors:  Mirna Marinić; Katelyn Mika; Sravanthi Chigurupati; Vincent J Lynch
Journal:  Elife       Date:  2021-02-01       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.